EC
EcoR1 Capital’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,049,405
| Closed | -$5.03M | – | 50 |
|
|
2024
Q4 | $5.03M | Buy |
+3,049,405
| New | +$5.03M | 0.19% | 42 |
|
|
2020
Q3 | – | Sell |
-619,855
| Closed | -$21.3M | – | 51 |
|
|
2020
Q2 | $21.3M | Sell |
619,855
-1,722,020
| -74% | -$59.1M | 1.57% | 20 |
|
|
2020
Q1 | $52M | Buy |
2,341,875
+1,890,521
| +419% | +$42M | 5.43% | 5 |
|
|
2019
Q4 | $8.83M | Buy |
+451,354
| New | +$8.83M | 0.8% | 25 |
|
|
2017
Q4 | – | Sell |
-2,262,678
| Closed | -$8.96M | – | 29 |
|
|
2017
Q3 | $8.96M | Sell |
2,262,678
-274,348
| -11% | -$1.09M | 1.19% | 20 |
|
|
2017
Q2 | $8.22M | Hold |
2,537,026
| – | – | 1.46% | 13 |
|
|
2017
Q1 | $11.5M | Buy |
+2,537,026
| New | +$11.5M | 2.92% | 10 |
|
|
2016
Q4 | – | Sell |
-590,527
| Closed | -$1.84M | – | 31 |
|
|
2016
Q3 | $1.84M | Buy |
+590,527
| New | +$1.84M | 0.57% | 23 |
|